| Overview |
| bs-6202R-PE-Cy5 |
| CIKS Polyclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Rat, Chicken |
| Human, Mouse, Dog, Cow, Pig, Rabbit |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CIKS/Nuclear Factor Kappa B Activator 1 |
| 501-574/574 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10758 |
| Cytoplasm, Nucleus, Secreted, Extracellular matrix |
| Act 1; ACT1; Activator of cAMP responsive element modulator CREM in testis; Adapter protein CIKS; C6ORF4; C6ORF5; C6ORF6; Chromosome 6 Open Reading Frame 4; Chromosome 6 Open Reading Frame 5; Chromosome 6 Open Reading Frame 6; CIKS; CIKS_HUMAN; Connection to IKK and SAPK / JNK; Connection to IKK and SAPK/JNK; Nuclear Factor Kappa B Activator 1; Nuclear factor NF kappa B activator 1; Nuclear factor NF-kappa-B activator 1; TRAF3 interacting protein 2; TRAF3-interacting protein 2; TRAF3IP2. |
| Could be involved in the activation of both NF-kappa-B via a NF-kappa-B inhibitor kinase (IKK)-dependent mechanism and stress-activated protein kinase (SAPK)/JNK. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz